Metabolic reprogramming by histone deacetylase inhibition preferentially targets NRF2-activated tumors

Dimitris Karagiannis(Columbia University Irving Medical Center), Chao Lü(Columbia University Irving Medical Center)
Cell Reports
December 30, 2023
Cited by 20


Related Papers